Skip to content

Clinical trials

Phase 2 Respiratory Tract Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 2 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20102
20112
20121
20131
20141
20151
20162
20173
20182
20193
20203
20211
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated4
Active, not recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Medicago3
Seqirus2
ADMA Biologics, Inc.1
Biomedical Advanced Research and Development Authority1
Cardeas Pharma1
Columbia University1
Emergent BioSolutions1
Furiex Pharmaceuticals, Inc1
Gary M Brittenham, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections31
Respiratory Tract Diseases13
Infections9
Virus Diseases9
Influenza, Human8
Orthomyxoviridae Infections6
Pneumonia6
RNA Virus Infections6
Lung Diseases5
COVID-194

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.